Answers are grounded in this paper and cite their sources.
In this study, tin oxide (SnO 2 ) solution mixtures containing indium (In) of 0%, 3%, 7%, 15%, and 30% were used to fabricate In- and N-codoped SnO 2 films on glass at 400 °C using an ultrasonic spray pyrolysis method combined with thermal annealing at 600 °C and post nitrogen plasma treatment. X-ray diffraction analysis demonstrated that the incorporation of elemental In in the SnO 2 film primarily induces the evolution of crystalline phases from In-doped SnO 2 to Sn-doped In 2 O 3, depending on the doping concentration. Upon exposure to N plasma, the dark current dramatically increases in proportion to the treatment duration (5–40 min); the dark current can be enhanced for the 3% and 7%-doped samples by as much as 3 orders of magnitude compared to the untreated samples. Hall measurements confirmed that hole carriers could dominate the SnO 2 host matrix to promote p-type properties at a low In content (3% and 7%) with an increase in resistance compared to undoped samples. However, samples with higher In content (15% and 30%) showed the opposite trend, due to the formation of a secondary phase of n-type In 2 O 3 . X-ray photoelectron spectroscopy was used to probe the incorporation and dissociation of chemical bonds between the doped In and N atoms in the SnO 2 . Moreover, depth profile measurements showed a correlation between the elemental compositions and elemental distributions of the codoped SnO 2 film. Current–voltage (I–V) characterization revealed the improved behavior of heterojunction diodes consisting of a p-type (In, N)-doped SnO 2 thin film deposited on n-type ZnO nanorod arrays.
No takes yet. Share an insight, caveat, or question.
Chantarat et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: